ZURA BIO LTD

Profile

Company Names

ZURA BIO LTD

Addresses

1489 W. WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV 89014

4225 EXECUTIVE SQUARE, SUITE 600, LA JOLLA, CA 92037

Phone Numbers

702-757-6133
858-247-0520

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

CAYMAN ISLANDS

Total Amount Raised:

$128,437,485.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-04-22 
$112,499,985.00 
$112,516,087.00 
$16,102.00 
Equity 
1
2023-05-01 
$15,937,500.00 
$79,996,220.00 
$64,058,720.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
VERENDER 
 
BADIAL 
EXECUTIVE OFFICER
ZURA BIO LTD
CHRISTOPHER 
 
CABELL 
EXECUTIVE OFFICER
PULMATRIX, INC.   |  ZURA BIO LTD   |  AESTHETICS360, INC.
KIM 
 
DAVIS 
EXECUTIVE OFFICER
CB-HDT HOLDINGS, INC.   |  ZURA BIO LTD
NEIL 
 
GRAHAM 
DIRECTOR
ZURA BIO LTD
MICHAEL 
 
HOWELL 
EXECUTIVE OFFICER
DOLLY, INC.   |  ZURA BIO LTD   |  AMYTRX THERAPEUTICS, INC.
JENNIFER 
 
JARRETT 
DIRECTOR
ZURA BIO LTD
SANDEEP 
 
KULKARNI 
DIRECTOR
ZURA BIO LTD   |  IMAGEPROVISION, INC.   |  DRAVITE THERAPEUTICS, INC.
ROBERT 
 
LISICKI 
EXECUTIVE OFFICER, DIRECTOR
ZURA BIO LTD   |  CADRENAL THERAPEUTICS, INC.
AMIT 
 
MUNSHI 
DIRECTOR
CYNVENIO BIOSYSTEMS INC   |  OXEIA BIOPHARMACEUTICALS, INC.   |  CYTRELLIS BIOSYSTEMS, INC.   |  PULMATRIX, INC.   |  ONEBIOPHARMA INC.   |  GALECTO, INC.   |  ZURA BIO LTD
GARRY 
 
NEIL 
DIRECTOR
ZURA BIO LTD
KIRAN 
 
NISTALA 
EXECUTIVE OFFICER
ZURA BIO LTD
ARNOUT 
 
PLOOS VAN AMSTEL 
DIRECTOR
ZURA BIO LTD
STEVEN 
 
SCHOCH 
DIRECTOR
23ANDME, INC.   |  ZURA BIO LTD
SOMEIT 
 
SIDHU 
DIRECTOR, EXECUTIVE OFFICER
ZURA BIO LTD
PARVINDER 
 
THIARA 
DIRECTOR
TMG VENTURES I LLC   |  ATHANOR FUND, LP   |  ATHANOR INTERNATIONAL FUND, LTD.   |  ZURA BIO LTD
GARY 
 
WHALE 
EXECUTIVE OFFICER
ZURA BIO LTD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-06
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-04-22 
2023-05-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2023-05-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
GUGGENHEIM SECURITIES, LLC
40638
NONE
NONE
RAYMOND JAMES FINANCIAL SERVICES, INC.
6694
NONE
NONE
CHARDAN CAPITAL MARKETS LLC
120128
NONE
NONE